53429 Use of Systemic Janus Kinase Inhibitors for Vitiligo: An Evidence-Based Review - 02/09/24
Doi : 10.1016/j.jaad.2024.07.388
Asfandyar Mufti, MD, FRCPC
Division of Dermatology, Department of Medicine, University of Toronto; Department of Dermatology, Sunnybrook Health Sciences Centre
Vimal Prajapati, MD, FRCPC
Division of Dermatology, Department of Medicine, University of Calgary; Dermatology Research Institute; Skin Health & Wellness Centre; Section of Community Pediatrics
Department of Pediatrics, University of Calgary; Section of Pediatric Rheumatology, Dep
Jensen Yeung, MD, FRCPC
Division of Dermatology, Department of Medicine, University of Toronto; Department of Dermatology, Sunnybrook Health Sciences Centre; Department of Dermatology, Women’s College Hospital; Probity Medical Research
Le texte complet de cet article est disponible en PDF.
| Commercial Support: NA. |
© 2024
Publié par Elsevier Masson SAS.
Vol 91 - N° 3S
P. AB96 - septembre 2024 Retour au numéro
Article précédent
- 52186 Use of Artificial Intelligence to Optimize Translated Skin Cancer Prevention Patient Handouts
- Helen Park, Sydney Dong, Sijia Zhang, Vy Xuan Pham, Jessica De La Rosa, Andres Cedeno, Anika Jallorina, Monica Guirgus, Bryan Sun, Regina Wang, George Hightower
- 52032 Validation and Feasibility of Patient-Reported Outcomes Information System Computer Adaptive Tests for Anxiety and Depression in Atopic Dermatitis: A Real-World Practice-Based Study
- Raj Chovatiya, Sheiva Fakhraie, Karishma Daftary, David Cella
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?